Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.87741 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.81572 | 36 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.81924 | 36 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.76193 | 36 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.75818 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.94784 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.89874 | 37 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.79231 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.78004 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78549 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.80073 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.78421 | 36 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.81251 | 36 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.81253 | 36 |